Trade Gilead ^GILD

Gilead Sciences, Inc. $GILD Shares Acquired by Arkadios Wealth Advisors

Gilead Sciences (GILD) Following Trodelvy Progress And A Fair Value Debate

Barclays Issues Pessimistic Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price

FY2027 EPS Estimates for Gilead Sciences Lowered by Analyst - Zolmax

Erste Group Bank Predicts Gilead Sciences FY2027 Earnings

The Manufacturers Life Insurance Company Has $173.14 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily

Gilead Sciences, Inc. $GILD Shares Bought by Waverly Advisors LLC

Gilead Sciences, Inc. $GILD Position Boosted by Amundi

Invasive mold infection in pediatric acute lymphoblastic leukemia-a detailed analysis of the clinical trial AIEOP-BFM ALL2009

Morgan Stanley says buy these quality stocks. They also pay dividends

Gilead Sciences (GILD) Expected to Post Quarterly Earnings on Monday

Gilead Sciences, Inc. $GILD Shares Bought by KCM Investment Advisors LLC

Quantinno Capital Management LP Buys 117,534 Shares of Gilead Sciences, Inc. $GILD - Markets Daily

Empowered Funds LLC Has $27.24 Million Stake in Gilead Sciences, Inc. $GILD - Zolmax

Empowered Funds LLC Increases Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Morgan Stanley Has Lowered Expectations for Gilead Sciences (NASDAQ:GILD) Stock Price

AstraZeneca Pressure Puts Krystal Biotech, TG Therapeutics And Gilead Stocks In Focus

#Aids2026: Daily pill. Monthly pill. Six-monthly jab. Why choice matters

Wealth Alliance LLC Sells 4,400 Shares of Gilead Sciences, Inc. $GILD - Markets Daily

Orbimed Advisors LLC Buys New Shares in Gilead Sciences, Inc. $GILD

Wealth Alliance LLC Cuts Stake in Gilead Sciences, Inc. $GILD - Stock Observer

Gilead (GILD) Wins Key Europe Backing For Trodelvy In Triple Negative Breast Cancer

Gilead Sciences, Inc. $GILD Shares Sold by Lombard Odier Asset Management Europe Ltd - Daily Political

OMERS ADMINISTRATION Corp Has $162.10 Million Stake in Gilead Sciences, Inc. $GILD - Daily Political

Best Pharmaceutical Stocks To Watch Now - July 25th

Gilead Sciences (GILD) Gets a Hold from RBC Capital

Hilltop Holdings Inc. Sells 8,156 Shares of Gilead Sciences, Inc. $GILD

Hilltop Holdings Inc. Reduces Stake in Gilead Sciences, Inc. $GILD - Zolmax

Epoch Investment Partners Inc. Sells 47,960 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Dai ichi Life Insurance Company Ltd Sells 13,858 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Pharmaceutical Stocks Worth Watching - July 21st - Zolmax

PNC Financial Services Group Inc. Has $67.77 Million Stock Position in Gilead Sciences, Inc. $GILD - Markets Daily

Public Employees Retirement System of Ohio Has $78.86 Million Stake in Gilead Sciences, Inc. $GILD - Stock Observer

Bank of Nova Scotia Decreases Stock Position in Gilead Sciences, Inc. $GILD

Sei Investments Co. Has $161.41 Million Position in Gilead Sciences, Inc. $GILD - Daily Political

Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study

Gilead Sciences, Inc. $GILD Shares Purchased by NewEdge Wealth LLC - Markets Daily

NewEdge Wealth LLC Raises Stake in Gilead Sciences, Inc. $GILD - Zolmax

Meiji Yasuda America Inc Increases Holdings in Gilead Sciences, Inc. $GILD - Markets Daily

Gilead Sciences, Inc. $GILD Holdings Decreased by Westpac Banking Corp

First Trust Advisors LP Buys 1,683,586 Shares of Gilead Sciences, Inc. $GILD

Gilead (GILD) Stock Could Still Trade At A Discount Following Its 127% Run

Gilead Sciences, Inc. $GILD Shares Bought by Meiji Yasuda America Inc - Stock Observer

Oslo Pensjonsforsikring AS Makes New $648,000 Investment in Gilead Sciences, Inc. $GILD - Stock Observer

Florida Financial Advisors LLC Lowers Position in Gilead Sciences, Inc. $GILD - Stock Observer

Gilead (GILD) Will Bring New HIV Data And A Merck Regimen To AIDS 2026

Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 | Morningstar

GILD: Once-Weekly Oral HIV Regime Maintains Virologic Suppression At Week 48

Pharmaceutical Stocks Worth Watching - July 21st - Stock Observer

Gilead Sciences' Quarterly Earnings Preview: What You Need to Know

Here Are Tuesday's Top Wall Street Analyst Research Calls: Adobe, Datadog, Five Below, Fortinet, Gilead Sciences, Goldman Sachs, Microsoft, Salesforce, and More

Summit Global Investments Trims Stock Position in Gilead Sciences, Inc. $GILD - Markets Daily

Summit Global Investments Cuts Holdings in Gilead Sciences, Inc. $GILD

Independent Financial Group LLC Takes Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Position Decreased by Convergence Investment Partners LLC

Gilead Sciences (NASDAQ:GILD) Downgraded by Leerink Partners to Market Perform - Daily Political

DJE Kapital AG Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Mosaic chromosomal alterations are suppressed in older adults with HIV

KBC Group NV Has $373.46 Million Stock Position in Gilead Sciences, Inc. $GILD - Zolmax

Pharmaceutical Stocks To Research - July 20th - Daily Political

KBC Group NV Has $373.46 Million Stake in Gilead Sciences, Inc. $GILD

Dimensional Fund Advisors LP Lowers Stock Holdings in Gilead Sciences, Inc. $GILD

FY2026 EPS Forecast for Gilead Sciences Boosted by Analyst

Swiss National Bank Buys 240,800 Shares of Gilead Sciences, Inc. $GILD

SEB Asset Management AB Invests $171.84 Million in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Financiere des Professionnels Fonds d investissement inc. - Markets Daily

Dorsey Wright & Associates Acquires New Stake in Gilead Sciences, Inc. $GILD - Markets Daily

Swiss National Bank Has $507.45 Million Holdings in Gilead Sciences, Inc. $GILD - Stock Observer

Assetmark Inc. Cuts Stock Position in Gilead Sciences, Inc. $GILD

Jennison Associates LLC Has $176.24 Million Stake in Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Stock Tops 3 GARP Picks Trading On More Measured Valuations

Gilead Sciences synthesizes new KRAS mutant inhibitors

Jag Capital Management LLC Increases Stake in Gilead Sciences, Inc. $GILD

Sigma Planning Corp Sells 7,783 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Bought by D.A. Davidson & CO.

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

Is Gilead Sciences (GILD) Fully Valued Following Mixed Earnings And A Full Year EPS Miss?

Sanctuary Advisors LLC Cuts Stock Holdings in Gilead Sciences, Inc. $GILD

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial

Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?

Should Gilead's Revenue Beat but Softer EPS Outlook Require Action From Gilead Sciences (GILD) Investors?

Diversify Wealth Management LLC Acquires 5,072 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Bleakley Financial Group LLC Acquires 24,649 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Calamos Advisors LLC Raises Stock Holdings in Gilead Sciences, Inc. $GILD

J. Safra Sarasin Holding AG Lowers Stock Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by Analysts - Zolmax

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Brokerages

AMF Tjanstepension AB Buys 17,302 Shares of Gilead Sciences, Inc. $GILD

Procyon Advisors LLC Increases Stock Position in Gilead Sciences, Inc. $GILD - Stock Observer

Teachers Retirement System of The State of Kentucky Has $85.62 Million Holdings in Gilead Sciences, Inc. $GILD - Daily Political

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

The Week Ahead: ISM services, SMCI

Week ahead: Wall Street’s Magnificent Seven earnings are up

Week ahead: Earnings season climax

Week ahead: RBA poised to hike?

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk